Skip to main content
Top
Published in: European Journal of Epidemiology 11/2019

01-11-2019 | Type 2 Diabetes | CORRESPONDENCE

Interaction between co-morbidities and cancer survival

Authors: Andrew G. Renehan, Nasra N. Alam, Matthew Sperrin

Published in: European Journal of Epidemiology | Issue 11/2019

Login to get access

Excerpt

Comorbidities, for example, cardiovascular disease (CVD), diabetes, and chronic kidney disease, commonly co-occur in patients with cancer. For example, in the EPIC-Heidelberg Study [1], the prevalence of multi-morbidity (≥ 2 concurrent chronic diseases) was present in up to two-thirds of individuals aged 50 to 75 years. There is a large volume of evidence that, not unsurprisingly, the presence of a co-morbidity prognosticates for worse survival. In turn, this invites cancer health professionals to explore opportunities to intervene to lessen the risks of comorbidity-associated mortalities among cancer survivors. These patients have regular healthcare contact and are often well-motivated, with opportunities to exploit teachable moments. By example, the American Cancer Society Colorectal Cancer (CRC) Survivorship Care Guidelines [2] recommend that patients are informed of the adverse effects of obesity on CVD risk. …
Literature
Metadata
Title
Interaction between co-morbidities and cancer survival
Authors
Andrew G. Renehan
Nasra N. Alam
Matthew Sperrin
Publication date
01-11-2019
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 11/2019
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-019-00547-w

Other articles of this Issue 11/2019

European Journal of Epidemiology 11/2019 Go to the issue